These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

181 related items for PubMed ID: 16269466

  • 1. Insulin receptor kinase-associated phosphotyrosine phosphatases in hepatic endosomes: assessing the role of phosphotyrosine phosphatase-1B.
    Li C, Baquiran G, Gu F, Tremblay ML, Fazel A, Bergeron JJ, Posner BI.
    Endocrinology; 2006 Feb; 147(2):912-8. PubMed ID: 16269466
    [Abstract] [Full Text] [Related]

  • 2. Early signaling events triggered by peroxovanadium [bpV(phen)] are insulin receptor kinase (IRK)-dependent: specificity of inhibition of IRK-associated protein tyrosine phosphatase(s) by bpV(phen).
    Band CJ, Posner BI, Dumas V, Contreres JO.
    Mol Endocrinol; 1997 Dec; 11(13):1899-910. PubMed ID: 9415395
    [Abstract] [Full Text] [Related]

  • 3. A role for tyrosine phosphorylation in both activation and inhibition of the insulin receptor tyrosine kinase in vivo.
    Drake PG, Bevan AP, Burgess JW, Bergeron JJ, Posner BI.
    Endocrinology; 1996 Nov; 137(11):4960-8. PubMed ID: 8895369
    [Abstract] [Full Text] [Related]

  • 4. Selective activation of the rat hepatic endosomal insulin receptor kinase. Role for the endosome in insulin signaling.
    Bevan AP, Burgess JW, Drake PG, Shaver A, Bergeron JJ, Posner BI.
    J Biol Chem; 1995 May 05; 270(18):10784-91. PubMed ID: 7537739
    [Abstract] [Full Text] [Related]

  • 5. Regulation of insulin receptor kinase activity by endosomal processes: possible areas for therapeutic intervention.
    Posner BI.
    Curr Opin Investig Drugs; 2003 Apr 05; 4(4):430-4. PubMed ID: 12808882
    [Abstract] [Full Text] [Related]

  • 6. Association of phosphatidylinositol 3-kinase with the insulin receptor: compartmentation in rat liver.
    Drake PG, Balbis A, Wu J, Bergeron JJ, Posner BI.
    Am J Physiol Endocrinol Metab; 2000 Aug 05; 279(2):E266-74. PubMed ID: 10913025
    [Abstract] [Full Text] [Related]

  • 7. ATP-dependent desensitization of insulin binding and tyrosine kinase activity of the insulin receptor kinase. The role of endosomal acidification.
    Contreres JO, Faure R, Baquiran G, Bergeron JJ, Posner BI.
    J Biol Chem; 1998 Aug 21; 273(34):22007-13. PubMed ID: 9705342
    [Abstract] [Full Text] [Related]

  • 8. Insulin receptor-associated protein tyrosine phosphatase(s): role in insulin action.
    Drake PG, Posner BI.
    Mol Cell Biochem; 1998 May 21; 182(1-2):79-89. PubMed ID: 9609117
    [Abstract] [Full Text] [Related]

  • 9. Insulin Signalling: The Inside Story.
    Posner BI.
    Can J Diabetes; 2017 Feb 21; 41(1):108-113. PubMed ID: 27614806
    [Abstract] [Full Text] [Related]

  • 10. Protein tyrosine phosphatase-1B dephosphorylation of the insulin receptor occurs in a perinuclear endosome compartment in human embryonic kidney 293 cells.
    Romsicki Y, Reece M, Gauthier JY, Asante-Appiah E, Kennedy BP.
    J Biol Chem; 2004 Mar 26; 279(13):12868-75. PubMed ID: 14722096
    [Abstract] [Full Text] [Related]

  • 11. Peroxovanadium compounds: biological actions and mechanism of insulin-mimesis.
    Bevan AP, Drake PG, Yale JF, Shaver A, Posner BI.
    Mol Cell Biochem; 2004 Mar 26; 153(1-2):49-58. PubMed ID: 8927047
    [Abstract] [Full Text] [Related]

  • 12. Peroxyvanadium compounds inhibit glucose-6-phosphatase activity and glucagon-stimulated hepatic glucose output in the rat in vivo.
    Westergaard N, Brand CL, Lewinsky RH, Andersen HS, Carr RD, Burchell A, Lundgren K.
    Arch Biochem Biophys; 1999 Jun 01; 366(1):55-60. PubMed ID: 10334863
    [Abstract] [Full Text] [Related]

  • 13. Peroxovanadium compounds. A new class of potent phosphotyrosine phosphatase inhibitors which are insulin mimetics.
    Posner BI, Faure R, Burgess JW, Bevan AP, Lachance D, Zhang-Sun G, Fantus IG, Ng JB, Hall DA, Lum BS.
    J Biol Chem; 1994 Feb 11; 269(6):4596-604. PubMed ID: 8308031
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Molecular mechanisms involved in the antiproliferative action of protein tyrosine phosphatase inhibitor potassium bisperoxo(1,10-phenanthroline)oxovanadate.
    Ban J, Maysinger D, Kovac V, Galetić I, Matulić M, Hadzija M, Uzarević B.
    Life Sci; 2000 Dec 01; 68(2):165-75. PubMed ID: 11191635
    [Abstract] [Full Text] [Related]

  • 17. Insulin receptor internalization and signalling.
    Di Guglielmo GM, Drake PG, Baass PC, Authier F, Posner BI, Bergeron JJ.
    Mol Cell Biochem; 1998 May 01; 182(1-2):59-63. PubMed ID: 9609114
    [Abstract] [Full Text] [Related]

  • 18. A 60-kilodalton protein in rat hepatoma cells overexpressing insulin receptor was tyrosine phosphorylated and associated with Syp, phophatidylinositol 3-kinase, and Grb2 in an insulin-dependent manner.
    Zhang-Sun G, Yang C, Viallet J, Feng G, Bergeron JJ, Posner BI.
    Endocrinology; 1996 Jul 01; 137(7):2649-58. PubMed ID: 8770882
    [Abstract] [Full Text] [Related]

  • 19. Elevated protein tyrosine phosphatase activity and increased membrane viscosity are associated with impaired activation of the insulin receptor kinase in old rats.
    Nadiv O, Shinitzky M, Manu H, Hecht D, Roberts CT, LeRoith D, Zick Y.
    Biochem J; 1994 Mar 01; 298 ( Pt 2)(Pt 2):443-50. PubMed ID: 8135754
    [Abstract] [Full Text] [Related]

  • 20. Inhibition of a Src homology 2 domain containing protein tyrosine phosphatase by vanadate in the primary culture of hepatocytes.
    Pugazhenthi S, Tanha F, Dahl B, Khandelwal RL.
    Arch Biochem Biophys; 1996 Nov 15; 335(2):273-82. PubMed ID: 8914924
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.